Innovating Works

BIOEMTECH

Desconocido
PHENOMENO: PHYSICAL BREAST ANTHROPOMORPHIC MODELS AND TECHNOLOGY FOR THEIR PRODUCTION BIOEMISSION TECHNOLOGY SOLUTIONS IKE participó en un H2020 H2020-MSCA-RISE-2020 Breast cancer is the most common incident form of cancer among women bellow seventy years of age. Early diagnosis is recognized as a critica...
2020-11-24 - 2025-04-30 | Financiado
UNAT: Ultra small Nanohybrides for Advanced Theranostics BIOEMISSION TECHNOLOGY SOLUTIONS IKE participó en un H2020 H2020-MSCA-RISE-2020 Nowadays, research focusing on control and use of nanomaterials in different areas including life sciences has become a key driver of innova...
2020-10-23 - 2026-03-31 | Financiado
PEPSA-MATE: Nanopeptides and Nanosaccharides for Advanced and Sustainable Materials BIOEMISSION TECHNOLOGY SOLUTIONS IKE participó en un H2020 H2020-MSCA-RISE-2019 Long-range research and innovation goal towards transformative biomaterials and technologies: The long-range goal of PEPSA-MATE is to develo...
2019-09-24 - 2025-08-31 | Financiado
B2B: Modeling spontaneous Breast cancer metastasis TO the Bone with a first of its kind 3D device that re... BIOEMISSION TECHNOLOGY SOLUTIONS IKE participó en un H2020 H2020-FETOPEN-2016-2017 Cancer patients developing a metastatic disease are considered incurable. Breast cancer hits 1 woman in 8, and its most common metastatic si...
2018-05-25 - 2022-12-31 | Financiado
POLYTHEA: Design and photo optimization of Photosensitizer for Human Health and Food security applications or... BIOEMISSION TECHNOLOGY SOLUTIONS IKE participó en un H2020 H2020-MSCA-ITN-2017 The development of active compounds that can efficiently fight microbial infections and cancer are of utmost importance for food security an...
2018-02-27 - 2022-06-30 | Financiado
nTRACK: Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regen... BIOEMISSION TECHNOLOGY SOLUTIONS IKE participó en un H2020 H2020-NMBP-2016-2017 Cell therapy offers promising opportunities to approach several diseases for which no effective therapies are currently available. However,...
2017-10-30 - 2022-03-31 | Financiado
CUPIDO: Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts BIOEMISSION TECHNOLOGY SOLUTIONS IKE participó en un H2020 H2020-NMBP-2016-2017 The incidence of Cardiovascular Disease (CD) claims worldwide 17.1 million lives a year, with an estimated 31% of all deaths globally and a...
2016-11-22 - 2021-01-31 | Financiado
ERROR: A pEdiatRic dosimetRy personalized platfORm based on computational anthropomorphic phantoms BIOEMISSION TECHNOLOGY SOLUTIONS IKE participó en un H2020 H2020-MSCA-RISE-2015 The main objective of ERROR is to develop a new software tool, which will offer to the clinician the possibility to assess alternative imagi...
2015-10-05 - 2019-12-31 | Financiado
VIVOIMAG: Multimodal imaging of the in vivo fate of bone transplants BIOEMISSION TECHNOLOGY SOLUTIONS IKE participó en un H2020 H2020-MSCA-RISE-2014 The main objective of VIVOIMAG is to develop bone implants including a new contrast agent sensitive to enzymatic activity of metaloproteases...
2014-12-04 - 2019-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.